@linq-management.bsky.social✨New project: #REPhRAME
REPhRAME is an EU project advancing #PhageTherapy toward clinical practice.
The aim is to find innovative solutions to recurrent urinary tract infections and to assess a new therapeutic approach in a randomised #ClinicalTrial.
➡️ www.rephrame-project.eu
@thephage.bsky.socialInteliphage is seeking an experienced medical officer to help shape its clinical strategy, prepare for clinical trials, collaborate with its Clinical Advisory Board, and lead discussions with regulatory authorities.
@proseandpassion.mastodon.social.ap.brid.gy16-Sep-2026
First-of-its-kind preventative #phageTherapy provides promising results
@virusesmdpi.bsky.social👉Case report in Viruses: a severely burned patient with relapsing XDR P. aeruginosa VAP & bacteremia was successfully treated with personalized nebulized + IV phage therapy, combined with IFN-γ and imipenem-relebactam.
@phagelab.bsky.socialCould we fight AMR using phages targeting resistance plamids rather than the bacteria themselves?
Our latest paper from @uniofnottingham.bsky.social, discusses how phages can select for plasmid-free, antibiotic-sensitive bacteria.
@ijaa-isac.bsky.social🔥Check out the Hot Topic: www.sciencedirect.com/science/arti...
Growing interest in phage therapy but important knowledge gaps and barriers remain...🦠
@isacworld.bsky.social
@virusesmdpi.bsky.social🌊 Review in Viruses: Marine bacteriophages may offer new tools against antimicrobial resistance through phage therapy, phage–antibiotic synergy and phage-derived enzymes.
@healthcare-europe.bsky.socialA new study led by @microberamon.bsky.social from 🇬🇧 @oxengsci.bsky.social, with @ucl.ac.uk and @uniofleicester.bsky.social, shows that #phagetherapy could help to reduce recurrent #infections, which happen when the 🦠 bacteria responsible for #UTI s ‘hide’ in the tissue of the #bladder.
@microbiomecongress.bsky.social🧬 Phage delivery systems are evolving through genetic engineering, nanoparticles, liposomes & hydrogels—improving stability, targeting, penetration & controlled release for next-generation phage therapy.
@epstoa.bsky.social🗓️30/9 EP #STOAevent on #AntiMicrobialResistance
#AMR: a growing threat to global health, projected to cause 39 million deaths worldwide until 2050🦠
This workshop assesses #PhageTherapy as alternative to antibiotics
👉Info & register: https://link.europa.eu/KpWTfj
#EMA #ECDC